| Related Articles |
Severe Central Sleep Apnea Associated With Chronic Baclofen Therapy: A Case Series.
Chest. 2016 May;149(5):e127-31
Authors: Olivier PY, Joyeux-Faure M, Gentina T, Launois SH, d'Ortho MP, Pépin JL, Gagnadoux F
Abstract
Baclofen, a gamma-aminobutyric acid-B agonist with muscle-relaxant properties, is widely used in patients with severe spasticity. In animals, baclofen has been shown to decrease respiratory drive. In humans, however, use of baclofen at the standard dose did not significantly impair sleep-disordered breathing in a susceptible population of snorers. Recently, there has been increasing interest in the role of baclofen for the treatment of alcohol dependence. We describe severe central sleep apnea (CSA) in four patients with none of the conditions commonly associated with CSA who were receiving chronic baclofen therapy for alcohol withdrawal. In one patient, baclofen withdrawal was associated with a complete resolution of CSA. Three patients were treated by adaptive servo-ventilation while continuing their treatment with baclofen. Given the increasing number of patients receiving baclofen for alcohol withdrawal treatment, physicians should be aware that these patients might be affected by severe CSA. Future studies are required to determine the mechanisms, prevalence, and treatment modalities of sleep-disordered breathing associated with baclofen usage.
PMID: 27157226 [PubMed - in process]
from #ENT-PubMed via ola Kala on Inoreader http://ift.tt/1YjxkyB
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου